| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/18/2009 | US7576200 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 08/18/2009 | US7576178 DADD, death activator death domain protein |
| 08/18/2009 | US7576130 Tetramethyltetradecanetetraols as anticarcinogenic, anticholesterol, antidiabetic and hypotensive agents; metabolic disorders, peroxisome proliferator activated receptor associated disorder, Alzheimer's Disease, obesity, pancreatitis; increased HDL levels and lowers LDL levels; combination therapy |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576095 2-(p-Alkoxy- or p-fluoroalkylsulonyloxyphenyl)-1-phenyl-5-cyclohexyl- or 5-(1-piperdinyl)-4,5-dihydropyrrolo[3,2-c]pyridin-4-ones; treatment of obesity, psychiatric and neurological disorders |
| 08/18/2009 | US7576064 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 08/18/2009 | US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 08/18/2009 | US7576050 Glucagon-like peptides and ependins for use in treatment and prevention of diabetes and neurodegenerative conditions; neuroprotective agents; neurotrophic factors |
| 08/18/2009 | US7575577 Devices and methods for the restoration of a spinal disc |
| 08/18/2009 | CA2585557C Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2481591C Stabilized ascorbic acid derivatives |
| 08/18/2009 | CA2429270C Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/18/2009 | CA2315141C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 08/18/2009 | CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product |
| 08/13/2009 | WO2009100326A1 Abca-1 elevating compounds and the use thereof |
| 08/13/2009 | WO2009100318A1 1b20 pcsk9 antagonists |
| 08/13/2009 | WO2009100297A1 1d05 pcsk9 antagonists |
| 08/13/2009 | WO2009100181A2 Absorbent ingestible agents and associated methods of manufacture and use |
| 08/13/2009 | WO2009100171A1 Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 08/13/2009 | WO2009100037A1 Methods for treating a condition characterized by dysfunction in protein homeostasis |
| 08/13/2009 | WO2009099988A2 Method and apparatus for fat removal |
| 08/13/2009 | WO2009099820A2 Modulating body weight |
| 08/13/2009 | WO2009099392A1 Compositions of phytosterols with enhanced bioavailability |
| 08/13/2009 | WO2009099171A1 Pharmaceutical product |
| 08/13/2009 | WO2009099086A1 3-substituted sulfonyl piperazine derivative |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098501A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid |
| 08/13/2009 | WO2009098490A1 Antimicrobial agents for the treatment of campylobacter species in the crop of a bird |
| 08/13/2009 | WO2009097999A1 Aryl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097998A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097735A1 Use of compounds extracted from momordica charantia l. in the manufacture of medicaments for prevention and treatment of diabetes and obesity |
| 08/13/2009 | WO2009071086A3 Probiotic bacteria and regulation of fat storage |
| 08/13/2009 | WO2009056737A3 Novel nacl salt substitute, use thereof and products containing same |
| 08/13/2009 | WO2009050201A3 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 08/13/2009 | WO2009043525A3 Use of the combination of gluten exorphin c and cd36 as a therapeutic agent |
| 08/13/2009 | WO2009043477A3 Use of glpl (7-36) alone or in combination with leptin 22-56 as a therapeutic agent |
| 08/13/2009 | WO2009043453A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009043436A3 Use of af12198 as a therapeutic agent |
| 08/13/2009 | WO2009040031A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009039991A3 Use of aviptadil as a therapeutic agent |
| 08/13/2009 | WO2009033792A3 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent |
| 08/13/2009 | WO2009033770A3 Calcitonin c-terminal flanking peptide for use as a therapeutic agent |
| 08/13/2009 | WO2008148839A3 Long-acting polymeric prodrugs of exendin |
| 08/13/2009 | WO2008108958A8 Benzimidazole derivatives and methods of use thereof |
| 08/13/2009 | US20090203791 Nateglinide-containing preparation |
| 08/13/2009 | US20090203780 Use of a Polyunsaturated Fatty Acid Compound |
| 08/13/2009 | US20090203778 Fatty acid analogues, i.e. including dha derivatives for uses as a medicament |
| 08/13/2009 | US20090203773 Compounds for the Treatment of Non-Autoimmune Type 2 Diabetes Mellitus and/or Syndrome X |
| 08/13/2009 | US20090203755 Use of crf1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia |
| 08/13/2009 | US20090203751 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/13/2009 | US20090203750 5-HT2C Receptor Agonists as Anorectic Agents |
| 08/13/2009 | US20090203734 F1f0-atpase inhibitors and related methods |
| 08/13/2009 | US20090203710 Novel piperidine derivative |
| 08/13/2009 | US20090203705 Spiro Compounds As NPY Y5 Receptor Antagonists |
| 08/13/2009 | US20090203695 Compounds IV |
| 08/13/2009 | US20090203689 Abca-1 elevating compounds and methods |
| 08/13/2009 | US20090203676 G-protein Coupled Receptor Agonists |
| 08/13/2009 | US20090203668 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/13/2009 | US20090203656 Method for the Reduction of Dangerous Blood Sugar Levels |
| 08/13/2009 | US20090203655 Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation |
| 08/13/2009 | US20090203651 Use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and metabolic syndrome |
| 08/13/2009 | US20090203638 Pharmaceutical compositions and methods for metabolic modulation |
| 08/13/2009 | US20090203633 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/13/2009 | US20090203615 Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administration |
| 08/13/2009 | US20090203608 reducing lipid accumulation in an adipocyte; finding a therapeutic agents for treating obesity, diabetes, arteriosclerosis |
| 08/13/2009 | US20090203605 Methods For Treating A Condition Characterized By Dysfunction In Protein Homeostasis |
| 08/13/2009 | US20090203604 Soothing agent and food for treating fatigue |
| 08/13/2009 | US20090203602 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 08/13/2009 | US20090203589 Chemically modified human growth hormone receptor antagonist conjugates |
| 08/13/2009 | US20090203580 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 08/13/2009 | US20090203578 Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use |
| 08/13/2009 | US20090203577 Azepinoindole Derivatives As Pharmaceutical Agents |
| 08/13/2009 | US20090203576 Methods and compositons for pulmonary delivery of insulin |
| 08/13/2009 | US20090202659 Modulation of Peripheral Clocks in Adipose Tissue |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202608 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 08/13/2009 | US20090202566 Use of the ENDO-180 gene and polypeptide for diagnosis and treatment |
| 08/13/2009 | US20090202506 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma |
| 08/13/2009 | US20090202494 Combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| 08/13/2009 | US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2714516A1 Abca-1 elevating compounds and the use thereof |
| 08/13/2009 | CA2714480A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | CA2714181A1 Ampk modulators |
| 08/13/2009 | CA2713899A1 Antimicrobial agents for the treatment of campylobacter species in the crop of a bird |
| 08/13/2009 | CA2713409A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid |
| 08/13/2009 | CA2713380A1 Compositions of phytosterols with enhanced bioavailability |
| 08/13/2009 | CA2713361A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 08/13/2009 | CA2711794A1 1d05 pcsk9 antagonists |
| 08/13/2009 | CA2711791A1 1b20 pcsk9 antagonists |
| 08/13/2009 | CA2711399A1 3-substituted sulfonylpiperidine derivative |
| 08/12/2009 | EP2088157A1 Collagen peptide composition and food or beverage containing the same |
| 08/12/2009 | EP2087903A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 08/12/2009 | EP2087895A1 Use of selenium yeasts in the treatment of diabetes |
| 08/12/2009 | EP2087892A2 (S,S) reboxetine for treating age associated learning and mental disorders |
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2087889A2 Controlled release oral tablet having a unitary core |